Understanding available resources for substance misuse and addiction

Aug. 2025Important Notices

Information available on the internet can be overwhelming when searching on the topic of substance misuse and addiction. UPMC Health Plan has a dedicated webpage containing information and links to treatment service options, harm reduction services, and other supports. The webpage includes local, state, and national resources to help streamline the search process for members and their families who may be experiencing challenges related to substance misuse and addiction, and for providers who may be looking for information on how to best support their patients.  

The webpage provides links to:

  • Resources on identifying signs of overdose and how to respond to an overdose event.
  • Substance use treatment services and supports, including medication treatment options for alcohol, opioids, and tobacco; inpatient withdrawal management and residential treatment services; outpatient; crisis support; and peer recovery services.
  • State-funded resources for substance misuse and addiction and other social determinants of health for Pennsylvania, Maryland, and New York.
  • Harm reduction services.
  • Crisis information.
  • Support group information for individuals and for families.

Visit upmchealthplan.com/members/condition-support/substance-misuse-and-addiction for more information.


Recent Announcements

Clinical workflow changes through Epic®

Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.
Sep. 2026Important Notices

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates